During the past decade, Katharinen Hospital Unna conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Katharinen Hospital Unna" #1 sponsor was "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 3 trials, followed by "ResMed" with 3 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored and "MicroPort CRM" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Katharinen Hospital Unna" #1 collaborator was "CRI-The Clinical Research Institute GmbH" with 1 trials as a collaborator, "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 1 trials as a collaborator and "Spectrum Pharmaceuticals, Inc" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Katharinen Hospital Unna" are "Lymphoma" (3 trials), "Heart Failure" (2 trials), "Breast Cancer" (1 trials), "Breast Neoplasms" (1 trials) and "CD20+ Aggressive B-Cell Lymphoma" (1 trials). Many other conditions were trialed in "Katharinen Hospital Unna" in a lesser frequency.

Most popular intervention types in "Katharinen Hospital Unna" are "Drug" (6 trials), "Device" (4 trials), "Biological" (3 trials), "Radiation" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (3 trials), "doxorubicin hydrochloride" (3 trials), "prednisone" (3 trials), "radiation therapy" (3 trials) and "vincristine sulfate" (3 trials). Other intervention names were less common.

The vast majority of trials in "Katharinen Hospital Unna" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Katharinen Hospital Unna". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Katharinen Hospital Unna, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Katharinen Hospital Unna, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".